Clusterin is a highly conserved glycoprotein which has been proposed to pro
tect host cells against complement-mediated cytolysis, We tested the hypoth
esis that clusterin is a complement regulator using erythrocytes and cells
which had been stably transfected with a membrane-anchored form of clusteri
n as targets for complement-mediated cytolysis. Clusterin gave dose-depende
nt protection of antibody-coated sheep erythrocytes against complement-medi
ated lysis by diluted normal human serum. There was a linear relationship b
etween the concentration of clusterin giving 50% protection and the concent
ration of serum; extrapolation of this to the case of undiluted human serum
showed that a clusterin concentration at least two orders of magnitude gre
ater than its physiological plasma concentration would be needed to confer
protection against complement-mediated cytolysis under physiological condit
ions. Physiological concentrations of clusterin did not protect rabbit eryt
hrocytes against alternative complement pathway-mediated lysis using dilute
human serum. Exogenous clusterin had no effect on lysis of human erythrocy
tes triggered by the addition of inulin to autologous human serum. Inductio
n of cell-surface clusterin expression by L929 (murine fibroblast) cells wh
ich had been stably transfected with cDNA for human clusterin linked to DNA
coding for the 44 C-terminal amino acid residues of CD55 did not protect t
he cells against complement-mediated lysis by either normal or clusterin-de
pleted human serum. These data suggest that clusterin may not be a physiolo
gically relevant regulator of complement activation. (C) 1999 Academic Pres
s.